Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging

Author(s): Victor W. Pike

Journal Name: Current Medicinal Chemistry

Volume 23 , Issue 18 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


The development of reversibly binding radioligands for imaging brain proteins in vivo, such as enzymes, neurotransmitter transporters, receptors and ion channels, with positron emission tomography (PET) is keenly sought for biomedical studies of neuropsychiatric disorders and for drug discovery and development, but is recognized as being highly challenging at the medicinal chemistry level. This article aims to compile and discuss the main considerations to be taken into account by chemists embarking on programs of radioligand development for PET imaging of brain protein targets.

Keywords: PET, radioligand, molecular imaging, positron-emitter, carbon-11, fluorine-18, efflux transporter, blood-brain barrier.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 20 June, 2016
Page: [1818 - 1869]
Pages: 52
DOI: 10.2174/0929867323666160418114826
Price: $65

Article Metrics

PDF: 151
HTML: 17
PRC: 1